Where can I learn more about this study?
You can find more information about this study on the websites listed below.
- www.clinicaltrials.gov Once you are on the website, type "NCT04532918" into the search box and click "Search".
- www.clinicaltrialsregister.eu Once you are on the website, click "Home and Search", then type "2020-000937-42" in the search box and click "Search".
- www.AstraZenecaClinicalTrials.com Once you are on the website, type "D5495C00013" into the search box and click "Find a Study".

Full Study Title: An Open-label, 3-Treatment, 3-Period, Fixed Sequence Study in Healthy Subjects to Assess the Pharmacokinetics of Verinurad and Allopurinol when Administered Alone, and in Combination with Single Doses of Cyclosporine or Rifampicin
AstraZeneca AB Protocol Number: D5495C00013
National Clinical Trials Number: NCT04532918
EudraCT Number: 2020-000937-42

AstraZeneca AB sponsored this study and has its headquarters in Södertälje, Sweden.

Thank you!
Clinical study participants belong to a large community of people who take part in clinical research around the world. They help researchers answer important health questions and find medical treatments for patients.

The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP | One Liberty Square, Suite 1100 • Boston, MA 02109 | 1-877-MED-HERO | www.ciscrp.org

Version 1.0_2021_12_16